Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,855 papers from all fields of science
Search
Sign In
Create Free Account
R 84760
Known as:
R-84760
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Pyrrolidines
Thiazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Rapid, real-time sampling of R-84760 in blood by in vivo microdialysis with tandem mass spectrometry.
N. Kobayashi
,
M. Kazui
,
T. Ikeda
Journal of Pharmaceutical and Biomedical Analysis
2000
Corpus ID: 1702547
1999
1999
Quantitative analysis of R-84760, a selective kappa-opioid receptor agonist, in plasma by liquid chromatography with electrospray ionization tandem mass spectrometry.
N. Kobayashi
,
H. Naganuma
Journal of Pharmaceutical and Biomedical Analysis
1999
Corpus ID: 43711834
1998
1998
Effects of R-84760, a selective kappa-opioid receptor agonist, on nociceptive reflex in isolated neonatal rat spinal cord.
K. Fujibayashi
,
K. Kubota
,
K. Saito
European Journal of Pharmacology
1998
Corpus ID: 19760168
1996
1996
Effects of R-84760, a selective kappa-opioid receptor agonist, on nociception, locomotion and respiration in rats.
K. Fujibayashi
,
M. Kubota-Watanabe
,
Y. Iizuka
Archives internationales de pharmacodynamie et de…
1996
Corpus ID: 28029814
The effects of R-84760 [(3R)-3-(1-pyrrolidinylmethyl)-4-[(1S)-5,6-dichloro-l-indancarb onyl] tetrahydro-1,4-thiazine…
Expand
1994
1994
Pharmacological properties of R-84760, a novel kappa-opioid receptor agonist.
K. Fujibayashi
,
K. Sakamoto
,
M. Watanabe
,
Y. Iizuka
European Journal of Pharmacology
1994
Corpus ID: 25937490
The pharmacological properties of a structurally novel kappa-opioid receptor agonist, (3R)-3-(1-pyrrolidinylmethyl)-4-[(1S)-5,6…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE